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Open aSummary
Purpose: Pulmonary rehabilitation (PR) has positive effects on exercise capacity in Chronic
Obstructive Pulmonary Disease (COPD). However, not all COPD patients benefit from PR to
the same extent. We investigated whether there is a patient profile, which is associated with
the improvement in endurance exercise capacity.
Methods: In this observational study, we included 102 COPD patients who followed PR (age
60  10 (mean  SD) years, FEV1%predicted 44  16%, 54 men). Lung function, maximal incre-
mental cycle testing (Wpeak, VO2peak, Dlactate), quadriceps force and incremental and
endurance shuttle walk test (ISWT/ESWT) were performed at the start of PR. The ESWT was
repeated after 7 weeks of PR.
Results: Mean change in ESWT (DESWT) was 100  154%. Four variables showed a statistically
significant negative correlation with DESWT: FEV1%pred. (r Z 0.20), Wpeak (r Z 0.24),
Dlactate (rZ 0.33) and incremental shuttle walk test (ISWT) (rZ 0.31). A cluster analysis
identified two patient profiles: A profile with high DESWT, TLC and RV and low FEV1, VO2peak,COPD, Chronic Obstructive Pulmonary Disease; EKG, Electrocardiogram; ESWT, Endurance Shuttle
lume in one second; FVC, Forced Vital Capacity; HADS, Hospital Anxiety and Depression Scale; HR,
Walk Test; PR, Pulmonary Rehabilitation; RV, Residual Volume; TLC, Total Lung Capacity; VE, Minute
tput; VO2, Oxygen Uptake; Wpeak, Peak Work Rate; DESWT, Change in endurance shuttle walk test
ary rehabilitation; Dlactate, Change in lactate concentration during maximal incremental exercise
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Predictors of pulmonary rehabilitation outcome 695quadriceps force, Dlactate, HRpeak%pred. and ISWT distance and a profile with low DESWT, TLC
and RV and high FEV1, VO2peak, quadriceps force, Dlactate, HRpeak%pred. and ISWT distance.
Conclusions: Single variables from lung function or exercise testing at baseline have limited
predictive value for response to exercise training.
However, patients with worse disease status (i.e. a combination of lower FEV1, more hyper-
inflation, lower exercise capacity and worse quadriceps force) improve more in endurance
exercise capacity.
ª 2011 Elsevier Ltd. Open access under the Elsevier OA license.Introduction
In patients with COPD strength and endurance exercise
capacity are impaired.1e4 Exercise capacity may be
affected by many factors such as ventilatory limitation,
dynamic hyperinflation and diminished oxygen uptake in
the lung.5 In addition, impaired exercise capacity could be
caused by factors outside the lung, such as early lactate
production,2,6e8 muscle dysfunction1 and cardiovascular
deconditioning (e.g. higher heart rate and lower stroke
volume during exercise),9,10 which may at least be partially
induced by sedentary lifestyle due to dyspnea.11
Pulmonary rehabilitation (PR) has beneficial effects on
exercise-induced dyspnea, exercise capacity and daily
physical activity level in COPD.12e16 In addition, it is known
in healthy subjects that exercise training can reverse the
process of deconditioning and delays the anaerobic
threshold during exercise.17 Not all COPD patients benefit
from PR to the same extent, as is shown in several stud-
ies.18e22 The limiting factor in exercise may play a role in
the response to PR. For instance, the presence of a marked
ventilatory reserve is associated with improvement in
exercise capacity after PR in two studies.20,22 Besides that,
the presence of cardiovascular limitation is associated with
improvement in exercise capacity after PR as well.19,20
Finally, reduced muscle strength is found to be associated
with improvement in exercise capacity after PR.18,20
These studies are, however, quite difficult to compare as
they show differences in patient selection, rehabilitation
program, outcome measures and statistical methods
used.18e22
In a well defined patient group we investigated whether
a patient profile exists with a combination of variables
instead of a single variable, which may predict the degree
of improvement in endurance exercise capacity after PR.
To reveal this profile, the cluster analysis technique was
used. We hypothesized that patients with better lung
function combined with more signs of deconditioning, e.g.
high lactate production during maximal exercise testing
and low peak exercise capacity show the largest improve-
ment in endurance exercise capacity after PR.
Methods
Design
A post-hoc analysis was performed on data from patients
participating in a PR program in a PR center. At baseline,standardized pulmonary function testing, maximal incre-
mental cycle testing, and incremental andendurance shuttle
walk tests (ISWT and ESWT) were performed. After seven
weeks of exercise training the ESWTwas repeated.
Subjects
In this study 102 COPD patients, who participated in the PR
program of the Center for Rehabilitation of the University
Medical Center Groningen, were included. Inclusion criteria
were a diagnosis of COPD according to the GOLD guidelines
and the capability of following an endurance exercise
program and filling out questionnaires. Patients were free
of exacerbations for at least six weeks. Excluded were
patients with musculoskeletal disorders and malignant
diseases which would interfere with exercise training. Both
outpatients and inpatients were included. If necessary,
patients were assigned to the inpatient PR program based
on criteria such as travel distance, dependence in activities
of daily life and nutritional status, in accordance with the
ATS/ERS statement.23 All patients consented to the scien-
tific use of data from tests they performed.
Pulmonary function testing
Spirometry to determine FEV1 and FVC was performed in
the sitting position using a spirometer (Masterlab, Viasys
Healthcare), and static lung volumes were determined with
a bodyplethysmograph (Masterlab, Viasys Healthcare).
Tests were performed following accepted standards.24
Exercise testing
Subjects performed a symptom-limited incremental cycle
test (1-min increments of 5 or 10 W) to the limit of toler-
ance on an electromagnetically braked cycle ergometer
(OxyconPro, Viasys Healthcare) after a 5-min rest, followed
by 1 min of unloaded pedaling. Peak work rate was defined
as the highest work level reached and maintained at
a pedaling frequency of 60 revolutions per minute for at
least 30 s. Pulmonary oxygen uptake, pulmonary carbon
dioxide output and minute ventilation were recorded using
a mixing chamber. Heart rate was determined using the
ReR interval from a 12-lead on-line electrocardiogram.
Arterial blood was drawn from a line in the radial or
brachial artery for the analysis of arterial oxygen tension,
carbon dioxide tension and lactate, at rest, every 2 min
during the test and 2 min after stopping (Rapidlab,
696 W.A. Altenburg et al.Siemens). The change in lactate concentration from rest to
the highest level, either at maximal work load or 2 min
after stopping the test (Dlactate), was used for further
analyses.
Endurance exercise capacity was measured at the start
of and after PR, using the endurance shuttle walk test
(ESWT). The ESWT was developed as a standardized field
test to assess endurance capacity using constant walking
speeds and external regulation of pace.25 This test is based
on the incremental shuttle walk test (ISWT), which uses
a 10 m course and the walking speed is externally
controlled by acoustic signals.26 The patient is instructed to
walk for as long as possible. Patients have to reach the end
of the course in time before the audio signal; when they fail
to do so, or when they indicate they are exhausted, the test
is ended. This test was performed once at the start of PR.
VO2peak can be predicted by the performance on ISWTwith
the equation: VO2peak (ml/min/kg) Z 4.19 þ 0.025
(distance in meters).27 For the ESWT a speed was used that
corresponded with 85% of the VO2peak. The ESWT speed
was read from a graph which related shuttle walking speeds
to predicted VO2peak.
25 While the ISWT measures maximal
exercise capacity in COPD patients, the ESWT is considered
to better reflect the endurance exercise capacity.25,27 The
ESWT appears to be responsive to change after an inter-
vention, perhaps even more than the ISWT and the 6 min
walking distance.25,28
Quadriceps strength was measured with a handheld
dynamometer (microFET), with the patient in sitting posi-
tion, the knee at 90, and the leg vertical.29
Pulmonary rehabilitation
The exercise sessions in the PR program aimed at improving
endurance exercise capacity. Training forms used to ach-
ieve increased endurance capacity were cycling, walking,
swimming and sports, 3 sessions per week, 1e2 h. All
patients participated in all these exercise training modali-
ties. The target of each training session was to achieve
a training stimulus of 30 min at 60e70% of the peak work
load achieved on maximal incremental cycle testing. In
cycling, training intensity was based on work load, whereas
in other training modalities the intensity was based on
heart rate or Borg scores. The progression of the training
load during the exercise program was individually tailored.
In addition, subjects followed educational courses and
received psychological and/or nutritional support if
necessary. The program meets the criteria of the ACSM and
ATS/ERS.23,30,31
Statistical analysis
Statistical analysis was performed using SPSS version 16.0.
A p-value below 0.05 (two-sided) was considered statisti-
cally significant. Means and standard deviations (SD) were
calculated if the outcome variables were normally distrib-
uted. Normality was tested with the KolmogoroveSmirnov
or ShapiroeWilks tests. Spearman’s r was calculated
because the primary outcome measure, percentage change
in endurance shuttle walk test (DESWT), was not normally
distributed.Discriminant analysis, method enter (meaning that all
variables are taken into the model whether they contribute
significantly or not) was performed to find predictors of
improved endurance exercise capacity. The outcome vari-
able DESWT was divided in two groups using the median.
A K-means cluster analysis was used to find homoge-
neous groups with characteristic profiles showing different
response to rehabilitation, measured with the ESWT.
Cluster analysis is a datamining technique, in which all
subjects are assigned to a predetermined number of rela-
tively homogeneous subgroups. These groups are formed by
comparing Euclidean distances between each subject, and
each cluster centre in an interactive process. Within these
groups the consistency of the variables is high. In this
analysis we used the highest and lowest tertile of DESWT
scores, because we opted for finding patient profiles which
were associated with high or low improvement in endur-
ance exercise capacity.Results
In this study 102 COPD patients were included: 5 GOLD I, 28
GOLD II, 50 GOLD III and 19 GOLD IV patients. Character-
istics of the total group are shown in Table 1. The mean age
of the patients was 60  10 (mean  SD) years, and the
male/female ratio was almost equal. The number of missed
exercise sessions was <8%. Maximal exercise capacity was
below normal values as shown by the decreased predicted
peak work load (41.5%  22.1%) and predicted peak oxygen
uptake (54.5%  16.3%). After 7 weeks of PR mean DESWT
was 100%  154%, corresponding with an absolute ESWT
distance improvement of 188  446 m and an improvement
in ESWT time of 216  418 s. Of all patients 24% improved
between 10% and 50%, whereas 52% improved more than
50%.
The correlations between various physiological factors
and the DESWT are shown in Table 2. Four variables showed
a weak but significant negative correlation with the DESWT:
Dlactate, FEV1%pred, ISWT distance and Wpeak.
Discriminant analysis (method enter) was used to further
explore predictive factors for DESWT and we included the
variables in the model which are currently known or sug-
gested as predictors. In our final model Dlactate appeared
to be the strongest contributing factor in the equation
explaining 33% of the variance (Table 3). However, the
model was not statistically significant (Wilk’s
LambdaZ 0.888, pZ 0.372) although 65.3% of the patients
were classified correctly.
The K-means cluster analysis revealed the presence of
two homogeneous groups, which were significantly
different on several variables i.e. DESWT, FEV1%pred., TLC
%pred, RV%TLC, Wpeak, quadriceps force, VO2peak, Dlac-
tate, HRpeak%pred. and ISWT distance (Table 4). A high
DESWT was associated with a patient profile with high TLC
and RV%TLC and low FEV1%pred., Wpeak, VO2peak, HRpeak
%pred., quadriceps strength, ISWT distance. A low DESWT
was associated with a patient profile with low TLC and RV%
TLC and high FEV1%pred., Wpeak, VO2peak, HRpeak%pred.,
quadriceps strength, ISWT distance. The clusters showed no
significant differences for age and BMI.
Table 1 Baseline patient characteristics (N Z 102).
Demographics
Age (y) 60  10
Female/Male 48/54
BMI (kg/m2) 27.3  6.1
Pulmonary function
FEV1 (l) 1.27  0.59
FEV1 (% pred) 44.2  15.9
TLC (% pred) 117.9  19.7
RV%TLC (%) 54.8  10.3
Exercise tests
ISWT (m) 233  131
ESWT (m) 409  350
ESWT (sec) 390  274
Quadriceps force (N) 292  82
Maximal incremental
exercise testing
Rest Peak exercise
VO2 (% pred) 54.5  16.3
Wpeak (%pred) 41.5  22.1
Wpeak (W) 53.8  36.3
VO2 (ml/min) 278.7  100.6 971.0  371.2
HR (b/min) 88  16 119  22
VE (l) 11.8  4.0 35.8  15.2
PaCO2 (kPa) 5.27  0.67 5.70  1.02
PaO2 (kPa) 9.38  1.25 8.58  1.72
Lactate (mmol/l) 1.62  0.88 4.90  2.50
Borgscore dyspnea 1 (0e3) 7 (5e9)
Borgscore fatigue 0.5 (0e2) 7 (5e9)
Values given as a mean  sd or median (IQR).
BMI: body mass index; FEV1: forced expiratory volume in 1 s;
TLC: total lung capacity; RV: residual volume; ISWT: incre-
mental shuttle walk test; ESWT: endurance shuttle walk test;
VO2: oxygen uptake; Wpeak: peak work rate; HR: heart rate;
VE: minute ventilation; PaCO2: arterial carbon dioxide tension;
PaO2: arterial oxygen tension.
Table 2 Correlations of initial measures with DESWT
(Spearman’s r).
DESWT (%)
Age (y) n.s.
BMI (kg/m2) n.s.
FEV1 (l) n.s.
FEV1 (%pred) r Z 0.20*
TLC (% pred) n.s.
RV%TLC (%) n.s.
ISWT (m) r Z 0.31*
Quadriceps force (N) n.s.
VO2peak (ml/min) n.s.
Wpeak (W) r Z 0.24*
HRpeak%predicted (%) n.s.
Dlactate (mmol/l) r Z 0.33*
*p < 0.05, n.s.: non significant correlation.
BMI: body mass index; FEV1: forced expiratory volume in 1 s;
TLC: total lung capacity; RV: residual volume; ISWT: incre-
mental shuttle walk test; VO2peak: peak oxygen uptake;
Wpeak: peak work rate; HR: heart rate; Dlactate: Change in
lactate concentration before and after maximal incremental
exercise testing.
Table 3 Discriminant analysis: Structure Matrix.
Canonical discriminant
function coefficient
Dlactate (mmol/) 0.374
Wpeak (W) 0.312
Quadriceps force (N) 0.283
BMI (kg/m2) 0.276
FEV1 (% pred) 0.271
RV%TLC (%) 0.258
TLC (%pred) 0.231
Age (y) 0.185
VO2peak (ml/min) 0.159
HRpeak%predicted (%) 0.031
Canonical correlation Z 0.335, Wilks Lambda Z 0.888,
p Z 0.372.
Patients classified correctly Z 65.3%.
Dlactate: Change in lactate concentration before and after
maximal incremental exercise testing, Wpeak: peak work rate;
BMI: body mass index; FEV1: forced expiratory volume in 1 s; RV:
residual volume; TLC: total lung capacity; VO2peak: peak
oxygen uptake; HR: heart rate.
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This study shows that four variables measured at the start
of a PR program are correlated with the change in endur-
ance exercise capacity after 7 weeks of exercise training in
COPD: FEV1%pred, Wpeak, Dlactate and ISWT distance. As
we expected, patients with lower Wpeak and ISWT distance
improved more. However, opposite to what we expected, it
appeared that lower values of FEV1 and Dlactate correlate
with a larger improvement in endurance exercise capacity
after PR. In addition to this univariate analysis, the cluster
analysis, used to detect patient profiles, shows that two
homogeneous groups can be formed: a patient profile with
a combination of worse lung function and exercise capacity,
showing a larger improvement in endurance exercise
capacity, and a patient profile with a combination of better
lung function and exercise capacity, showing a substantially
smaller improvement.
A number of other investigators have examined whether
the change in exercise capacity can be predicted.18e22
Their results are equivocal and difficult to interpret. The
differences in results may be due to differences in patientselection, outcome measures, intervention and statistical
methods used to analyze the data. Garrod et al. studied
a very heterogeneous group of COPD patients from primary
and secondary care, who followed either outpatient or, for
the most severe patients, home-based PR, for 7 weeks,
twice a week for 1 h.18 The 6 MWD was the primary outcome
measure for exercise capacity, and the minimal clinically
important difference was used to determine if a patient
was a responder. A logistic regression analysis was used and
no predictors for the observed change in exercise capacity
were found. Plankeel et al. included non-oxygen dependent
COPD patients following a 4-week PR program and found
Table 4 K-means cluster analysis: Cluster profile.
Final cluster Centers ANOVA
1 (n Z 17) 2 (n Z 48) F p
DESWT (%) 40.2 141.3 4.281 .043
FEV1 (% pred) 57.9 39.1 23.133 .000
TLC (% pred) 108.1 122.8 7.203 .009
RV%TLC (%) 45.9 60.0 30.219 .000
Wpeak (W) 100.0 41.0 55.937 .000
Quadriceps
force (N)
337 269 9.171 .004
VO2peak (ml/min) 1530.2 801.7 101.686 .000
Dlactate (mmol/l) 5.19 2.74 16.547 .000
HRpeak%
predicted (%)
83 72 12.439 .001
ISWT (m) 364 199 28.491 .000
Age (y) 60 60 0.011 0.919
BMI (kg/m2) 29.8 26.5 3.325 0.073
p-values < 0.05 printed bold. DESWT: Change in endurance
shuttle walk test percentage, before and after pulmonary
rehabilitation; FEV1: forced expiratory volume in 1 s; TLC: total
lung capacity; RV: residual volume; Wpeak: peak work rate;
VO2peak: peak oxygen uptake; Dlactate: Change in lactate
concentration before and after maximal incremental exercise
testing; HR: heart rate; ISWT: incremental shuttle walk test;
BMI: body mass index.
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exercise testing, whether it was cardiovasculary, ventila-
tory, both or none, did not predict the increase in endur-
ance exercise capacity, measured with the 6 MWD.19
Interestingly, this study showed that the increase in
VO2peak after PR was highest in subjects with no ventila-
tory limitation. Recently, Vagaggini et al. studied moderate
to severe COPD patients who followed an 8-week outpa-
tient PR program.21 The effect of the PR program was
measured with the 6 MWD. Using a logistic regression
analysis, they found that patients with BMI >25 kg/m2 and
patients with PO2 < 8 Kpa (60 mmHg) improved more in
exercise capacity after PR. Troosters et al. studied
moderate to severe COPD patients following a 12 week
outpatient PR program.20 They used a discriminant analysis
to distinguish between responder and nonresponders.
Responders were defined by having a 15% increase in
maximal work load and/or 25% increase in 6 MWD. They
found that responders had more ventilatory reserve and
lower inspiratory and peripheral muscle strength. Zu Wal-
lack et al studied pulmonary patients, of which 80% had
a primary diagnosis of COPD, after a 6-week PR program.22
The effect of the program was measured with the 12 MWD.
Using a regression analysis they showed that a combination
of higher FEV1 and low initial walking distance on 12 MWD
predicted improvement in exercise capacity. Together the
above described results suggest that a worse functional
status may be related to a larger improvement in endur-
ance exercise capacity after exercise training.
Our study adds to previous results by including
a heterogeneous group of patients and using a different
statistical approach, the cluster analysis. Besides that wethink that the outcome measure in our study, the ESWT is
a sensitive measurement tool to assess changes in endur-
ance capacity after PR, as it has shown to be responsive to
change after an intervention.28 We found a lower FEV1 to be
associated with a higher improvement in exercise capacity
in contrast to some studies,19,20,22 which showed that
patients with some ventilatory reserve improved the most
after PR. However, the negative association we found
between improvement in exercise capacity after PR and
initial exercise testing is in line with other studies.19,22 An
explanation for the larger improvement of the patients with
low initial exercise capacity in our study may be that these
patients have entered a downward spiral of dyspnea,
avoidance of physical activity, deconditioning and demoti-
vation.9 These deconditioned and demotivated patients
may have a larger capacity for improvement than patients
with more preserved exercise capacity and thus may show
larger improvement after exercise training. The finding that
patients with a lower lactate production improve more than
patients with higher lactate production is confusing. The
literature until now states that high lactate at maximal
exercise testing is a reflection of poor (reversible) muscle
and/or cardiac function thus possibly predicting a positive
response to PR.2,6,19 The maximal incremental cycle test in
our study was symptom limited, and we believe that
patients really reached their maximal value, reflected by
high Borg scores on dyspnea and/or fatigue. That is why we
expected higher lactate levels at low exercise levels, which
reflect deconditioning, to be associated with larger
improvement in endurance exercise capacity. However, it
may be possible that in these severe COPD patients other
aspects than aerobic capacity determine maximal work
load or the change in walking distance. For instance,
neuromuscular efficiency and psychological factors such as
desensitization and self confidence may play a role.
There are some limitations to our study. In contrast with
many other studies, a considerable part of our patients
followed an inpatient PR program in a specialized rehabil-
itation centre, thus including more severe patients, even
those who are oxygen-dependent. This may limit the
extrapolation of our results to less severe COPD patients.
In our study we used data of a maximal incremental
cycle test to characterize patients at the start of our PR
program, and used an endurance walking test as a primary
outcome measure of change in endurance capacity. The
advantage of using a maximal incremental cycle test at the
beginning of PR is that more variables can be measured,
such as blood gases and lactate concentrations, and that
EKG-recordings can easily be made to assess exercise
safety. In addition, it is shown that the peak exercise
response is not different for VO2, tidal volume, respiratory
frequency and heart rate between an incremental shuttle
walking test and a maximal incremental cycle test.32
Finally, we focused on endurance capacity as an
outcome measure because we believe this is important for
functioning in daily life. However, to be able to select
patients that benefit from PR, changes in health related
quality of life and healthcare utilization after PR should be
investigated as well.
In our opinion, the results of the current study are
clinically relevant. Single variables from lung function or
maximal incremental exercise testing at entry of PR are of
Predictors of pulmonary rehabilitation outcome 699limited value in predicting the response to exercise
training. However, the cluster analysis shows that the more
severe COPD patients, i.e. patients with worse lung func-
tion combined with worse exercise capacity seem to benefit
more from PR, which provides a strong argument not to
exclude these severely disabled patients from PR programs.
We hypothesize that in these patients a downward spiral of
dyspnea, avoidance of physical activity, deconditioning and
demotivation exists. Therefore, we suggest that the role of
lifestyle and psychological factors such as low activity
pattern, demoralisation and demotivation may particularly
be important in these patients and should be investigated.
In conclusion, COPD patients with worse disease status,
i.e. lower FEV1, more signs of hyperinflation, lower exercise
capacity and worse quadriceps force improve more in
endurance exercise capacity after PR and should not be
excluded for treatment with PR.
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